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S550 AmPublic Health’s Future Role inMary C. White, ScD, Nikki S. Hayes, MPH, Lisa C. Richardson, MD, MPHIntroductionDespite modest reductions in the incidence ratesfor many cancers in recent years,1 the absolutenumber of people who will be diagnosed with
cancer and the number of cancer survivors are expected to
increase substantially over the next few decades in the U.S.,
due to changing demographics, an aging population, and
improvements in survival.2–4 Advances in treating child-
hood cancer have led to an increase in the number of
adolescents and young adults who are cancer survivors,
and the late effects of treatment can be substantial in this
age group.5 Most cancer survivors, however, are older than
age 65 years.6 The number of adults aged 65 and older is
projected to increase in the U.S. from 48million in 2015 to
74million by 2030.7 In the war on cancer, cancer survivors
are often wounded warriors with long-term sequelae
needing to be managed together with other chronic
conditions, such as hypertension, cardiovascular disease,
and diabetes.8–10 In addition, cancer survivors may be at
risk of developing other primary cancers because of shared
etiologic risk factors or the consequences of radiation
therapy or chemotherapy.11,12 The complex needs of the
continually growing number of cancer survivors cannot be
fully met by the current healthcare system.13–16
CDC has used interdisciplinary approaches to address the
public health needs of cancer survivors for more than a
decade.17 This article highlights some of the future directions
suggested by the research and programmatic activities
described in this special supplement to improve the health
of cancer survivors and the communities in which they live.The Critical Importance of Collaborations
Partnerships and coalitions with public and private
sector organizations are essential for effective publicvision of Cancer Prevention and Control, National Center for
ease Prevention and Health Promotion (NCCDPHP), CDC,
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gues19 described the Public Health Action Model for
Cancer Survivorship to illustrate how various partners
can collaborate across multiple levels to improve survival
and quality of life for cancer survivors. This approach is
used by CDC’s National Comprehensive Cancer Control
Program (NCCCP), which provides a coalition-based
approach to cancer prevention and control in all 50
states, the District of Columbia, seven tribes and tribal
groups, and seven U.S. Associated Paciﬁc Islands/terri-
tories. The majority (94%) of these cancer coalitions are
currently working in their communities to address the
public health needs of cancer survivors.20,21 A recent
assessment of the implementation of the National Action
Plan for Cancer Survivorship revealed that 64% of
NCCCP grantees include these strategies in their pro-
gram action plans.20 As examples, Underwood and
colleagues21 described activities being undertaken by
grantees under CDC’s NCCCP to address cancer survi-
vorship. In addition, CDC also provides a number of
smaller programs to support implementation of NCCCP
survivorship priorities, as described by Buchanan et al.17
This includes support for the National Cancer Survivor-
ship Resource Center, and the opportunities to continue
to build on and add to the Center’s resources are
tremendous.Meeting the Needs of Speciﬁc Survivor
Populations
Evidence gained from the experiences of NCCCP and
other programs demonstrate how speciﬁc population
needs can be met. As one current example, CDC funds a
consortium of national networks for populations experi-
encing tobacco use and cancer-related outcomes. An
emphasis on smoking cessation is important because
35% of cancer survivors aged 18–44 years in 2012
continued to smoke, compared with 22.7% of the general
population.22 These networks convene stakeholders from
across the country to provide guidance and resources for
public health programs to reduce tobacco- and cancer-
related disparities in racial/ethnic minority populations;
populations with mental illnesses; lesbian, gay, bisexual,sevier Inc. on behalf of American Journal of Preventive Medicine.
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and low-SES communities. These networks are com-
posed of stakeholders with invaluable insights, and they
should be heavily engaged as activities move forward to
address the unique health needs of cancer survivors from
disparate populations.
Smith and Hall23 summarized how cancer survivor-
ship research activities at CDC are aligned with the ﬁve
recommendations of the National Prevention Strategy
for reducing health disparities and outlined areas where
public health could advance health equity in cancer
survivorship. For cancer survivors who face social,
economic, and environmental disadvantages, access to
quality health care can be limited. In addition, these same
disadvantages can exacerbate the long-term physical,
emotional, psychological, and ﬁnancial consequences of
the cancer diagnosis. Public health is uniquely positioned
to reach and assist populations of underserved survivors.
Johnson-Turbes and colleagues24 shared ﬁndings from
an evaluation of an innovative online intervention aimed
at African-American women who had been diagnosed
with breast cancer before age 45 years. This evaluation
highlights the importance of working in partnership with
community representatives to be culturally appropriate,
and suggests a cost-effective approach for reaching
special groups of younger cancer survivors.
Hall and Smith25 summarized the decade-long imple-
mentation of a research agenda at CDC to understand
the information needs of men who are newly diagnosed
with localized prostate cancer. The body of collaborative
research they described revealed the need for health
communication products and decision tools to assist
men, their spouses, and their physicians with conversa-
tions about treatment choices. The goal is to allowmen to
make decisions based on their values and needs. Con-
sistent with the Public Health Action Model for Cancer
Survivorship,19 this research also demonstrated the
importance of recognizing the multilevel perspectives of
the decision-making triad of the patient (survivor),
caregiver (interpersonal), and provider (organizational).
Hall and Smith also discussed uncertainty about the
appropriate protocol for active surveillance for African
American men. Community–clinical partnerships and
community-based participatory research may be valuable
to ensure that the needed research is designed for
dissemination and implementation at the outset.
Expansion of Data on Survivors for Public
Health Action
In the Public Health Action Model for Cancer Survivor-
ship,19 surveillance and applied research are levers that
can facilitate change as well as one of the four publicDecember 2015health domains of the National Action Plan for Cancer
Survivorship.26 Ryerson et al.27 described the substantial
progress that has been made to enhance the ability of
cancer registries to address this data need. Restricted
registry data, including recently collected data on com-
parative effectiveness from ten registries belonging to the
National Program of Cancer Registries, is now available
to researchers through the Research Data Center of the
National Center for Health Statistics.28 Several innova-
tions to expand the use of cancer registry data demon-
strate opportunities for central cancer registries to
contribute in new ways to cancer survivorship initiatives
at the state and community levels. Continued work is
needed to fully capitalize on the existence of a nationwide
system of cancer surveillance in this country.
The data presented by Guy and colleagues29 on out-of-
pocket healthcare expenditures among younger cancer
survivors point to the urgent need for increased efforts at
multiple levels to address the economic impact of
healthcare expenditures on cancer survivors and their
families. Other authors have called for increased discus-
sions between physicians and patients about “ﬁnancial
toxicity” as a side effect of treatment.30 Communication
at the level of the individual survivor and provider may
be particularly useful when providing information to
those who are uninsured or underinsured. Actions taken
at the population level, however, are likely to have greater
impact.31 Removal of ﬁnancial barriers to the receipt of
needed medical care and preventive health services may
require changes at the policy level.32,33 For policy
considerations, cost expenditure data such as that pro-
vided by Guy et al. can be extremely useful to decision
makers.34
Disease Prevention and Health Promotion
After Treatment
Activities of NCCCP include efforts to institutionalize
the use of survivorship care plan standards that not only
summarize a survivor’s treatment care but also provide
descriptive follow-up plans to improve the survivor’s
health and quality of life. CCC coalitions are powerful
networks with the capacity to work with a number of
clinical and community partners to ensure cancer
survivors access to medical homes for post-treatment
services as well as support for community programs to
facilitate healthy behaviors.
New data on barriers and facilitators to adherence to
major guidelines for health promotion and cancer pre-
vention among long-term colorectal cancer survivors are
now available from the Prevention among Colorectal
Cancer Survivors study.35,36 The ﬁndings from Hawkins
and colleagues35 suggest the need for a comprehensive,
White et al / Am J Prev Med 2015;49(6S5):S550–S553S552multilevel approach to promote greater awareness of
dietary guidelines, including limiting alcohol, among
cancer survivors and their providers. Rodriguez and
colleagues36 reported that, compared with those who
reported no exercise, survivors who reported exercise at
levels below recommendations had higher scores for
physical and overall health-related quality of life. This
ﬁnding lends support to broader efforts to promote
modest increases in physical activity, such as walking.37
In addition, having two or more comorbid conditions
was signiﬁcantly associated with lower mean scores for
physical, mental, and overall health-related quality of life.
This latter ﬁnding suggests potential value in partnering
with other disease-speciﬁc programs to address the
health of cancer survivors in the context of multiple
morbidities.38,39
Buchanan et al.40 examined the prevalence of cognitive
impairment among breast cancer survivors and the level
of support received for these symptoms. These ﬁndings
point to a need for greater recognition of the importance
of psychosocial issues among younger breast cancer
survivors and referral and care for psychosocial pro-
blems. Broader community-level support is needed for
those who are experiencing neurocognitive effects from
chemotherapy and hormone therapy.Conclusions
Preventing premature death and disability among people
with a history of cancer, similar to other chronic diseases,
requires addressing risk factors at both the individual and
population levels and increasing collaborations between
clinical and community preventive services.41 The con-
siderable progress achieved in implementing the public
health strategies in the National Action Plan for Cancer
Survivorship26 has depended on numerous partnerships
at the national, state, and local levels. NCCCP programs
have demonstrated tremendous capacity and potential
for planning and implementing evidence-based interven-
tions to address many of the unmet needs of cancer
survivors. These programs can bridge clinical and com-
munity resources to support the full implementation of
survivorship care planning as well as chronic disease self-
management.
Although much progress has been made, more needs
to be done, especially as cancer survival rates continue to
increase.3,4 More progress also is needed in primary
cancer prevention, to reduce the number of new cancer
cases.42 CDC and its partners must reinvigorate efforts to
gather data to assess the needs of survivors from their
own point of view to inform programs, policies, and
practices. Through the application of public health data
and surveillance systems, the translation of population-based research for public health action, and the lever-
aging of new and existing partnerships at the national,
state, and local levels, innovative approaches can be
identiﬁed, evaluated, and implemented to improve the
lives of cancer survivors.Publication of this article was supported by the Centers for
Disease Control and Prevention, Division of Cancer Preven-
tion and Control.
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